Panel advocates improved understanding of hepatitis B and screening of high-r…
Management of hepatitis B is a challenge for physicians and patients due to an incomplete understanding of the disease course, complex treatment indications, and the lack of large studies focusing on important health outcomes. Following two days of expert presentation, a rigorous evidence review, and audience commentary, the independent, impartial panel’s draft statement is now available.
More: continued here
